article thumbnail

The EU HTA regulation: a new frontier for access to innovative technologies

European Pharmaceutical Review

1 The regulation is the culmination of a long debate between European Union (EU) Member States and health sector stakeholders, triggered by joint actions such as European Network for Health Technology Assessment (EUnetHTA) and formalised through the European Commission (EC)’s proposal in January 2018. European Commission; 2018. Lorgelly PK.,

article thumbnail

Voice is Becoming the Loudest Tool in the Exam Room

PM360

The line from the 2011 Pixar “Cars” sequel (trust me, as a parent of two, I have seen it countless times) points to the practical implication for voice technology. Health systems are signing off on network-wide solutions that use AI companions to record conversations, compile EHR notes, and even order tests and prescriptions.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Strengthening and transforming the pharmaceutical supply chain

European Pharmaceutical Review

A recent report from the US Food and Drug Administration (FDA) shows that while the number of new drug shortages has fallen significantly from a high of 250 in 2011 to 49 in 2022, there was an increase in new drug shortages year-on-year. Going forward, it is imperative for companies to invest in constructing more resilient supply networks.

article thumbnail

Top 12 Healthcare Technology Start-ups To Know

Medico Reach

Founder: Jacob Sattelmair Year of establishment: 2011 Headquarters: Boston, Massachusetts. They have developed mobile apps that are meant to: Provide patients with clinical and emotional support in crises Create a network of clinics and facilities to help patients find doctors easily.

article thumbnail

Patient centricity 101: How to create content that REALLY communicates

pharmaphorum

According to the European Commission and NIHR Clinical Research Network, between 2007 and 2011, delays for launching clinical trials rose by 90%. And with approximately one third of the clinical trial timeline spent in patient recruitment, delays in launching clinical trials will increase costs and drain resources.

article thumbnail

The Caregiver Vertical: How Pharma Engages

Pharma Marketing Network

Sunny White is an Editorial Advisory Board member for the Pharma Marketing Network with unique insights into how important caregivers are to the HCP/patient relationship and overall health outcomes. Becoming “the caregiver champion” positions pharma to better understand and contribute to this important member of the frontline care team.

Pharma 98
article thumbnail

The role of outsourcing in antibody drug manufacture

European Pharmaceutical Review

Other factors were listed related to the development process of inter-organisational collaboration networks in the R&D of mAbs. Findings included: “the size and complexity of the collaborative network continuously increased as dedicated biotech firms established new partnerships with existing pharmaceutical companies”.